⌘K

Login Start Free

Home/Filings/4/0001213900-23-067440

4//SEC Filing

Mikhak Zamaneh 4

Accession 0001213900-23-067440

CIK 0001733413other

View on SEC.gov Company Profile

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 8:00 AM ET

Size

4.8 KB

Accession

0001213900-23-067440

Insider Transaction Report

Form 4

Period: 2023-08-15

TFF Pharmaceuticals, Inc.TFFP

Chief Medical Officer

Transactions

Purchase
Common Stock
2023-08-15$0.25/sh+120,000$30,000→ 135,000 total

Footnotes (1)

[F1]Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother

Related Parties

1

filerCIK 0001962453

Filing Metadata

Form type: 4
Filed: Aug 14, 8:00 PM ET
Accepted: Aug 15, 8:00 AM ET
Size: 4.8 KB

View on SEC.gov